Patent · US Active

Method for the quantification of methylated DNA

US8703414B2 · kind B2 · utility

1Cited by
3References
21Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJul 20, 2006
Grant dateApr 22, 2014
Priority date
Expiry dateApr 5, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/6818
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The method according to the invention concerns in particular a method for the quantification of methylated DNA. For this purpose, the DNA to be examined is first transformed such that unmethylated cytosine is converted to uracil while 5-methylcytosine remains unchanged. Subsequently, the transformed DNA is amplified in the presence of a pair of real-time probes. For this, a probe is constructed, which is specific for the methylated or for the unmethylated state of the DNA, and a probe, which binds methylation-unspecifically to the amplificate. The ratio of the signal intensities of the probes or the CT values allows for the calculation of the degree of methylation of the examined DNA. The method according to the invention is suited particularly for the diagnosis and prognosis of cancer and other diseases associated with a change in the methylation status, as well as, prediction of adverse for side-effects of pharmaceuticals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.